_id
691311ecccc777a4e85d7f08
Ticker
LYEL
Name
Lyell Immunopharma Inc
Exchange
NASDAQ
Address
201 Haskins Way, South San Francisco, CA, United States, 94080
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.lyell.com
Description
Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The company develops therapies using various approaches, such as c-Jun overexpression and NR4A3 gene knockout, to endow functional resistance to exhaustion; Epi-R to generate population of stem-like T cells with reduced exhaustion and improved proliferation and antitumor activity; CD62L positive enrichment to generate CAR T cells with enhanced antitumor activity; and Stim-R, a proprietary synthetic-cell mimetic. It is also developing IMPT-314, a dual-targeting CD19/CD20 CAR T-cell product candidate that is in Phase 1/2 clinical development for the treatment of patients with aggressive relapsed/refractory large B-cell non-Hodgkin lymphoma; and solid tumors program which is in preclinical trial targeting solid tumor indications. Lyell Immunopharma, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
Last Close
33.41
Volume
51561
Current Price
34.46
Change
3.142771625261911
Last Updated
2025-12-02T11:29:30.464Z
Image
data:image/webp;base64,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
Ipo Date
2021-06-17T00:00:00.000Z
Market Cap
468922592
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.941
Sentiment Sources
3
Rating
2.75
Target Price
19
Strong Buy
0
Buy
0
Hold
3
Sell
1
Strong Sell
0
Current Quarter
2025-09-30
Revenue
15000
Cost Of Revenue
-
Gross Profit
15000
Operating Expenses
37268000
Operating Income
-37253000
Interest Expense
-
Pretax Income
-38846000
Net Income
-38846000
Eps
-2.126450624042041
Dividends Per Share
-
Shares Outstanding
21218217
Income Tax Expense
-
EBITDA
-36280000
Operating Margin
-248353.33333333334
Total Other Income Expense Net
-1593000
Cash
123575000
Short Term Investments
196049000
Receivables
-
Inventories
-
Total Current Assets
328201000
Property Plant Equipment
56634000
Total Assets
407965000
Payables
2568000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
78844000
Equity
329121000
Depreciation
2566000
Change In Working Capital
-136000
Cash From Operations
-28577000
Capital Expenditures
62000
Cash From Investing
3349000
Cash From Financing
50000000
Net Change In Cash
24771000
PE
-
PB
1.9127168427417272
ROE
-11.802953928798225
ROA
-9.521895260622848
FCF
-28639000
Fcf Percent
-1909.2666666666667
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
4.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
4.5
Growth Investing Score
3
Momentum Investing Score
2
Net Net Investing Score
3
Quality Investing Score
2.5
Value Investing Score
6
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
15000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
15000
Quarters > 0 > income Statement > operating Expenses
37268000
Quarters > 0 > income Statement > operating Income
-37253000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-38846000
Quarters > 0 > income Statement > net Income
-38846000
Quarters > 0 > income Statement > eps
-2.126450624042041
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
18268000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-36280000
Quarters > 0 > income Statement > operating Margin
-248353.33333333334
Quarters > 0 > income Statement > total Other Income Expense Net
-1593000
Quarters > 0 > balance Sheet > cash
123575000
Quarters > 0 > balance Sheet > short Term Investments
196049000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
328201000
Quarters > 0 > balance Sheet > property Plant Equipment
56634000
Quarters > 0 > balance Sheet > total Assets
407965000
Quarters > 0 > balance Sheet > payables
2568000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
78844000
Quarters > 0 > balance Sheet > equity
329121000
Quarters > 0 > cash Flow > net Income
-38846000
Quarters > 0 > cash Flow > depreciation
2566000
Quarters > 0 > cash Flow > change In Working Capital
-136000
Quarters > 0 > cash Flow > cash From Operations
-28577000
Quarters > 0 > cash Flow > capital Expenditures
62000
Quarters > 0 > cash Flow > cash From Investing
3349000
Quarters > 0 > cash Flow > cash From Financing
50000000
Quarters > 0 > cash Flow > net Change In Cash
24771000
Quarters > 0 > ratios > PE
-2.126450624042041
Quarters > 0 > ratios > PB
1.9127168427417272
Quarters > 0 > ratios > ROE
-11.802953928798225
Quarters > 0 > ratios > ROA
-9.521895260622848
Quarters > 0 > ratios > FCF
-28639000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-1909.2666666666667
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
8000
Quarters > 1 > income Statement > cost Of Revenue
3135000
Quarters > 1 > income Statement > gross Profit
8000
Quarters > 1 > income Statement > operating Expenses
47148000
Quarters > 1 > income Statement > operating Income
-47140000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-42684000
Quarters > 1 > income Statement > net Income
-42684000
Quarters > 1 > income Statement > eps
-2.885418779152302
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
14793000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-42562000
Quarters > 1 > income Statement > operating Margin
-589250
Quarters > 1 > income Statement > total Other Income Expense Net
4456000
Quarters > 1 > balance Sheet > cash
98804000
Quarters > 1 > balance Sheet > short Term Investments
177986000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
282214000
Quarters > 1 > balance Sheet > property Plant Equipment
60066000
Quarters > 1 > balance Sheet > total Assets
385453000
Quarters > 1 > balance Sheet > payables
3379000
Quarters > 1 > balance Sheet > short Term Debt
8510000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
86530000
Quarters > 1 > balance Sheet > equity
298923000
Quarters > 1 > cash Flow > net Income
-42684000
Quarters > 1 > cash Flow > depreciation
3135000
Quarters > 1 > cash Flow > change In Working Capital
-876000
Quarters > 1 > cash Flow > cash From Operations
-34458000
Quarters > 1 > cash Flow > capital Expenditures
168000
Quarters > 1 > cash Flow > cash From Investing
12647000
Quarters > 1 > cash Flow > cash From Financing
183000
Quarters > 1 > cash Flow > net Change In Cash
-21628000
Quarters > 1 > ratios > PE
-2.885418779152302
Quarters > 1 > ratios > PB
1.7053447877881596
Quarters > 1 > ratios > ROE
-14.279262552563704
Quarters > 1 > ratios > ROA
-11.073723644646687
Quarters > 1 > ratios > FCF
-34626000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-4328.25
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
7000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
7000
Quarters > 2 > income Statement > operating Expenses
57374000
Quarters > 2 > income Statement > operating Income
-57367000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-52195000
Quarters > 2 > income Statement > net Income
-52195000
Quarters > 2 > income Statement > eps
-0.1768734454316871
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
295098000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-53926000
Quarters > 2 > income Statement > operating Margin
-819528.5714285714
Quarters > 2 > income Statement > total Other Income Expense Net
5172000
Quarters > 2 > balance Sheet > cash
120328000
Quarters > 2 > balance Sheet > short Term Investments
180849000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
309178000
Quarters > 2 > balance Sheet > property Plant Equipment
67765000
Quarters > 2 > balance Sheet > total Assets
429798000
Quarters > 2 > balance Sheet > payables
3728000
Quarters > 2 > balance Sheet > short Term Debt
8238000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
93277000
Quarters > 2 > balance Sheet > equity
336521000
Quarters > 2 > cash Flow > net Income
-52195000
Quarters > 2 > cash Flow > depreciation
3441000
Quarters > 2 > cash Flow > change In Working Capital
-9554000
Quarters > 2 > cash Flow > cash From Operations
-54738000
Quarters > 2 > cash Flow > capital Expenditures
246000
Quarters > 2 > cash Flow > cash From Investing
69466000
Quarters > 2 > cash Flow > cash From Financing
1000
Quarters > 2 > cash Flow > net Change In Cash
14729000
Quarters > 2 > ratios > PE
-0.1768734454316871
Quarters > 2 > ratios > PB
30.218254076268643
Quarters > 2 > ratios > ROE
-15.510176185141491
Quarters > 2 > ratios > ROA
-12.144076985002258
Quarters > 2 > ratios > FCF
-54984000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-7854.857142857143
Quarters > 2 > health Score
26
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
11000
Quarters > 3 > income Statement > cost Of Revenue
5026000
Quarters > 3 > income Statement > gross Profit
11000
Quarters > 3 > income Statement > operating Expenses
201158000
Quarters > 3 > income Statement > operating Income
-201147000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-191935000
Quarters > 3 > income Statement > net Income
-191935000
Quarters > 3 > income Statement > eps
-0.7201009983529615
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
266539000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-57640000
Quarters > 3 > income Statement > operating Margin
-1828609.0909090908
Quarters > 3 > income Statement > total Other Income Expense Net
9212000
Quarters > 3 > balance Sheet > cash
105597000
Quarters > 3 > balance Sheet > short Term Investments
264930000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
379594000
Quarters > 3 > balance Sheet > property Plant Equipment
72939000
Quarters > 3 > balance Sheet > total Assets
490859000
Quarters > 3 > balance Sheet > payables
5366000
Quarters > 3 > balance Sheet > short Term Debt
7974000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
108035000
Quarters > 3 > balance Sheet > equity
382824000
Quarters > 3 > cash Flow > net Income
-191935000
Quarters > 3 > cash Flow > depreciation
5026000
Quarters > 3 > cash Flow > change In Working Capital
34000
Quarters > 3 > cash Flow > cash From Operations
-47242000
Quarters > 3 > cash Flow > capital Expenditures
44000
Quarters > 3 > cash Flow > cash From Investing
53505000
Quarters > 3 > cash Flow > cash From Financing
437000
Quarters > 3 > cash Flow > net Change In Cash
5298000
Quarters > 3 > ratios > PE
-0.7201009983529615
Quarters > 3 > ratios > PB
23.992576066286336
Quarters > 3 > ratios > ROE
-50.13661630409797
Quarters > 3 > ratios > ROA
-39.10186020832867
Quarters > 3 > ratios > FCF
-47286000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-4298.727272727273
Quarters > 3 > health Score
27
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
61000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
61000
Annuals > 0 > income Statement > operating Expenses
358816000
Annuals > 0 > income Statement > operating Income
-358755000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-342994000
Annuals > 0 > income Statement > net Income
-342994000
Annuals > 0 > income Statement > eps
-1.3117408597215847
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
261480000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-200643000
Annuals > 0 > income Statement > operating Margin
-588122.9508196721
Annuals > 0 > income Statement > total Other Income Expense Net
15761000
Annuals > 0 > balance Sheet > cash
105597000
Annuals > 0 > balance Sheet > short Term Investments
264930000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
379594000
Annuals > 0 > balance Sheet > property Plant Equipment
72939000
Annuals > 0 > balance Sheet > total Assets
490859000
Annuals > 0 > balance Sheet > payables
5366000
Annuals > 0 > balance Sheet > short Term Debt
7974000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
108035000
Annuals > 0 > balance Sheet > equity
382824000
Annuals > 0 > cash Flow > net Income
-342994000
Annuals > 0 > cash Flow > depreciation
19631000
Annuals > 0 > cash Flow > change In Working Capital
-3120000
Annuals > 0 > cash Flow > cash From Operations
-162394000
Annuals > 0 > cash Flow > capital Expenditures
464000
Annuals > 0 > cash Flow > cash From Investing
122424000
Annuals > 0 > cash Flow > cash From Financing
1326000
Annuals > 0 > cash Flow > net Change In Cash
-38644000
Annuals > 0 > ratios > PE
-1.3117408597215847
Annuals > 0 > ratios > PB
15.094947025264876
Annuals > 0 > ratios > ROE
-89.59574112385849
Annuals > 0 > ratios > ROA
-69.87627811652634
Annuals > 0 > ratios > FCF
-162858000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-2669.8032786885246
Annuals > 0 > health Score
26
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
130000
Annuals > 1 > income Statement > cost Of Revenue
20250000
Annuals > 1 > income Statement > gross Profit
130000
Annuals > 1 > income Statement > operating Expenses
247138000
Annuals > 1 > income Statement > operating Income
-247008000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-234632000
Annuals > 1 > income Statement > net Income
-234632000
Annuals > 1 > income Statement > eps
-0.9348521613017615
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
250983000
Annuals > 1 > income Statement > income Tax Expense
-10530000
Annuals > 1 > income Statement > EBITDA
-226758000
Annuals > 1 > income Statement > operating Margin
-190006.15384615384
Annuals > 1 > income Statement > total Other Income Expense Net
12376000
Annuals > 1 > balance Sheet > cash
145647000
Annuals > 1 > balance Sheet > short Term Investments
400576000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
554686000
Annuals > 1 > balance Sheet > property Plant Equipment
142317000
Annuals > 1 > balance Sheet > total Assets
750029000
Annuals > 1 > balance Sheet > payables
4817000
Annuals > 1 > balance Sheet > short Term Debt
6273000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
95077000
Annuals > 1 > balance Sheet > equity
654952000
Annuals > 1 > cash Flow > net Income
-234632000
Annuals > 1 > cash Flow > depreciation
20250000
Annuals > 1 > cash Flow > change In Working Capital
3421000
Annuals > 1 > cash Flow > cash From Operations
-163694000
Annuals > 1 > cash Flow > capital Expenditures
2686000
Annuals > 1 > cash Flow > cash From Investing
184048000
Annuals > 1 > cash Flow > cash From Financing
1743000
Annuals > 1 > cash Flow > net Change In Cash
22093000
Annuals > 1 > ratios > PE
-0.9348521613017615
Annuals > 1 > ratios > PB
8.468901995871454
Annuals > 1 > ratios > ROE
-35.82430468186982
Annuals > 1 > ratios > ROA
-31.283057055127202
Annuals > 1 > ratios > FCF
-166380000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1279.8461538461538
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
84683000
Annuals > 2 > income Statement > cost Of Revenue
16467000
Annuals > 2 > income Statement > gross Profit
84683000
Annuals > 2 > income Statement > operating Expenses
271741000
Annuals > 2 > income Statement > operating Income
-187058000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-183118000
Annuals > 2 > income Statement > net Income
-183118000
Annuals > 2 > income Statement > eps
-0.7411283794722358
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
247080000
Annuals > 2 > income Statement > income Tax Expense
-178364000
Annuals > 2 > income Statement > EBITDA
-169038000
Annuals > 2 > income Statement > operating Margin
-220.8920326393727
Annuals > 2 > income Statement > total Other Income Expense Net
3940000
Annuals > 2 > balance Sheet > cash
123554000
Annuals > 2 > balance Sheet > short Term Investments
516598000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
651295000
Annuals > 2 > balance Sheet > property Plant Equipment
166265000
Annuals > 2 > balance Sheet > total Assets
937561000
Annuals > 2 > balance Sheet > payables
3917000
Annuals > 2 > balance Sheet > short Term Debt
4534000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
104309000
Annuals > 2 > balance Sheet > equity
833252000
Annuals > 2 > cash Flow > net Income
-183118000
Annuals > 2 > cash Flow > depreciation
16466999
Annuals > 2 > cash Flow > change In Working Capital
-82015000
Annuals > 2 > cash Flow > cash From Operations
-169555000
Annuals > 2 > cash Flow > capital Expenditures
24276000
Annuals > 2 > cash Flow > cash From Investing
-11540000
Annuals > 2 > cash Flow > cash From Financing
10635000
Annuals > 2 > cash Flow > net Change In Cash
-170274000
Annuals > 2 > ratios > PE
-0.7411283794722358
Annuals > 2 > ratios > PB
6.553201192436382
Annuals > 2 > ratios > ROE
-21.976304887357006
Annuals > 2 > ratios > ROA
-19.531315829050055
Annuals > 2 > ratios > FCF
-193831000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-2.2889009600510137
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
10650000
Annuals > 3 > income Statement > cost Of Revenue
14535000
Annuals > 3 > income Statement > gross Profit
10650000
Annuals > 3 > income Statement > operating Expenses
225426000
Annuals > 3 > income Statement > operating Income
-214776000
Annuals > 3 > income Statement > interest Expense
1165000
Annuals > 3 > income Statement > pretax Income
-250219000
Annuals > 3 > income Statement > net Income
-250219000
Annuals > 3 > income Statement > eps
-1.0308192372022509
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
242738000
Annuals > 3 > income Statement > income Tax Expense
35282000
Annuals > 3 > income Statement > EBITDA
-201152000
Annuals > 3 > income Statement > operating Margin
-2016.6760563380283
Annuals > 3 > income Statement > total Other Income Expense Net
-35443000
Annuals > 3 > balance Sheet > cash
293828000
Annuals > 3 > balance Sheet > short Term Investments
320966000
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
626286000
Annuals > 3 > balance Sheet > property Plant Equipment
166639000
Annuals > 3 > balance Sheet > total Assets
1127406000
Annuals > 3 > balance Sheet > payables
3207000
Annuals > 3 > balance Sheet > short Term Debt
1169000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
197619000
Annuals > 3 > balance Sheet > equity
929787000
Annuals > 3 > cash Flow > net Income
-250219000
Annuals > 3 > cash Flow > depreciation
13624000
Annuals > 3 > cash Flow > change In Working Capital
4015000
Annuals > 3 > cash Flow > cash From Operations
-126249000
Annuals > 3 > cash Flow > capital Expenditures
65504000
Annuals > 3 > cash Flow > cash From Investing
-121573000
Annuals > 3 > cash Flow > cash From Financing
401244000
Annuals > 3 > cash Flow > net Change In Cash
153422000
Annuals > 3 > ratios > PE
-1.0308192372022509
Annuals > 3 > ratios > PB
5.7696115346848265
Annuals > 3 > ratios > ROE
-26.91143240333539
Annuals > 3 > ratios > ROA
-22.19422284429921
Annuals > 3 > ratios > FCF
-191753000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-18.004976525821597
Annuals > 3 > health Score
29
Valuation > metrics > PE
-2.126450624042041
Valuation > metrics > PB
1.9127168427417272
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-11.802953928798225
Profitability > metrics > ROA
-11.836039500184338
Profitability > metrics > Net Margin
-2589.733333333333
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.23955931101327474
Risk > metrics > Interest Coverage
-14.51792673421668
Risk > final Score
2
Risk > verdict
High
Liquidity > metrics > Current Ratio
127.8041277258567
Liquidity > metrics > Quick Ratio
127.8041277258567
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-1486
Prev Risks > 1
-73
Prev Risks > 2
54
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:48:15.840Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-13
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-2.13
Earnings History > 0 > eps Estimate
-2.6425
Earnings History > 0 > eps Difference
0.5125
Earnings History > 0 > surprise Percent
19.3945
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-12
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-2.89
Earnings History > 1 > eps Estimate
-0.1633
Earnings History > 1 > eps Difference
-2.7267
Earnings History > 1 > surprise Percent
-1669.7489
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-13
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.1784
Earnings History > 2 > eps Estimate
-0.17
Earnings History > 2 > eps Difference
-0.0084
Earnings History > 2 > surprise Percent
-4.9412
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-12
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.445
Earnings History > 3 > eps Estimate
-0.1925
Earnings History > 3 > eps Difference
-0.2525
Earnings History > 3 > surprise Percent
-131.1688
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-07
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.19
Earnings History > 4 > eps Estimate
-0.2
Earnings History > 4 > eps Difference
0.01
Earnings History > 4 > surprise Percent
5
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-07
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.18
Earnings History > 5 > eps Estimate
-0.1794
Earnings History > 5 > eps Difference
-0.0006
Earnings History > 5 > surprise Percent
-0.3344
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-06
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.2393
Earnings History > 6 > eps Estimate
-0.24
Earnings History > 6 > eps Difference
0.0007
Earnings History > 6 > surprise Percent
0.2917
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-28
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.2
Earnings History > 7 > eps Estimate
-0.23
Earnings History > 7 > eps Difference
0.03
Earnings History > 7 > surprise Percent
13.0435
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-07
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.17
Earnings History > 8 > eps Estimate
-0.25
Earnings History > 8 > eps Difference
0.08
Earnings History > 8 > surprise Percent
32
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-08
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.18
Earnings History > 9 > eps Estimate
-0.27
Earnings History > 9 > eps Difference
0.09
Earnings History > 9 > surprise Percent
33.3333
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-04
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.23
Earnings History > 10 > eps Estimate
-0.28
Earnings History > 10 > eps Difference
0.05
Earnings History > 10 > surprise Percent
17.8571
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-02-28
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.04
Earnings History > 11 > eps Estimate
-0.3
Earnings History > 11 > eps Difference
0.26
Earnings History > 11 > surprise Percent
86.6667
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-08
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.28
Earnings History > 12 > eps Estimate
-0.31
Earnings History > 12 > eps Difference
0.03
Earnings History > 12 > surprise Percent
9.6774
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-04
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.15
Earnings History > 13 > eps Estimate
-0.31
Earnings History > 13 > eps Difference
0.16
Earnings History > 13 > surprise Percent
51.6129
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-10
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.28
Earnings History > 14 > eps Estimate
-0.29
Earnings History > 14 > eps Difference
0.01
Earnings History > 14 > surprise Percent
3.4483
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-29
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.35
Earnings History > 15 > eps Estimate
-0.28
Earnings History > 15 > eps Difference
-0.07
Earnings History > 15 > surprise Percent
-25
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-12
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.2
Earnings History > 16 > eps Estimate
-0.27
Earnings History > 16 > eps Difference
0.07
Earnings History > 16 > surprise Percent
25.9259
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-12
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.89
Earnings History > 17 > eps Estimate
-0.36
Earnings History > 17 > eps Difference
-0.53
Earnings History > 17 > surprise Percent
-147.2222
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-06-18
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.84
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.84
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-3.1868
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-3.1868
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2019-12-31
Earnings History > 20 > report Date
2020-03-31
Earnings History > 20 > date
2019-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-2.8159
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-2.8159
Earnings History > 20 > surprise Percent
-
Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The company develops therapies using various approaches, such as c-Jun overexpression and NR4A3 gene knockout, to endow functional resistance to exhaustion; Epi-R to generate population of stem-like T cells with reduced exhaustion and improved proliferation and antitumor activity; CD62L positive enrichment to generate CAR T cells with enhanced antitumor activity; and Stim-R, a proprietary synthetic-cell mimetic. It is also developing IMPT-314, a dual-targeting CD19/CD20 CAR T-cell product candidate that is in Phase 1/2 clinical development for the treatment of patients with aggressive relapsed/refractory large B-cell non-Hodgkin lymphoma; and solid tumors program which is in preclinical trial targeting solid tumor indications. Lyell Immunopharma, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A1,820,634 Shares in Lyell Immunopharma, Inc. $LYEL Bought by ARCH Venture Management LLC Defense World
Read more →Lyell Immunopharma (NASDAQ:LYEL) Sets New 12-Month High - Should You Buy? MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$19
Analyst Picks
Strong Buy
0
Buy
0
Hold
3
Sell
1
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Medium
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 48.69% of the total shares of Lyell Immunopharma Inc
1.
ARCH VENTURE CORP(9.4769%)
since
2025/06/30
2.
MWG Management Ltd.(5.2475%)
since
2025/03/31
3.
Foresite Capital Management IV, LLC(4.1663%)
since
2025/06/30
4.
Orland Properties Ltd(3.9284%)
since
2025/03/31
5.
Decheng Capital LLC(3.0996%)
since
2025/03/31
6.
Almitas Capital LLC(3.0191%)
since
2025/06/30
7.
venBio Partners LLC(2.4646%)
since
2025/06/30
8.
Vanguard Group Inc(2.304%)
since
2025/06/30
9.
Foresite Capital Management V, LLC(2.1167%)
since
2025/06/30
10.
T. Rowe Price Associates, Inc.(1.5931%)
since
2025/06/30
11.
Alphabet Inc(1.5265%)
since
2025/06/30
12.
Vanguard Total Stock Mkt Idx Inv(1.4373%)
since
2025/07/31
13.
Citadel Advisors Llc(1.4121%)
since
2025/06/30
14.
T. Rowe Price Health Sciences(1.1045%)
since
2025/07/31
15.
SC China Holding Ltd(0.7928%)
since
2025/06/30
16.
BlackRock Inc(0.754%)
since
2025/06/30
17.
Geode Capital Management, LLC(0.5376%)
since
2025/06/30
18.
RBF LLC(0.5205%)
since
2025/06/30
19.
Woodline Partners LP(0.5123%)
since
2025/06/30
20.
Vanguard Institutional Extnd Mkt Idx Tr(0.4773%)
since
2025/07/31
21.
Fidelity Extended Market Index(0.2639%)
since
2025/07/31
22.
Schwab US Small-Cap ETFâ„¢(0.23%)
since
2025/08/30
23.
Johnson & Johnson(0.2143%)
since
2025/03/31
24.
Takeda Pharmaceutical Co Ltd(0.2143%)
since
2025/03/31
25.
iShares Biotechnology ETF(0.1817%)
since
2025/08/31
26.
TD Health Sciences - I(0.1307%)
since
2024/12/31
27.
SEI Tax-Managed Small/Mid Cap F (SIMT)(0.1105%)
since
2025/08/31
28.
Bridgeway Ultra-Small Company Market(0.0937%)
since
2025/06/30
29.
Goldman Sachs Asset Management, L.P.(0.0933%)
since
2025/03/31
30.
Fidelity Total Market Index(0.0927%)
since
2025/07/31
31.
Extended Equity Market Fund K(0.0901%)
since
2025/06/30
32.
Vanguard Health Care ETF(0.0887%)
since
2025/07/31
33.
T. Rowe Price Health Sciences Port(0.0743%)
since
2025/07/31
34.
Fidelity Series Total Market Index(0.0679%)
since
2025/07/31
35.
Invesco RAFI US 1500 Small-Mid ETF(0.0622%)
since
2025/08/29
36.
Galileo - Biotech Innovation Fund S USD(0.0521%)
since
2025/02/28
37.
NT Col R2000 Val Idx Fd -DC -L -TierFour(0.0471%)
since
2025/03/31
38.
JHFunds2 Health Sciences NAV(0.0362%)
since
2025/01/31
39.
Vanguard Instl Ttl Stck Mkt Idx Tr(0.0325%)
since
2024/12/31
40.
State Street Russell 2000 Value CIT(0.0203%)
since
2025/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-2.13
EPS Estimate
-2.6425
EPS Difference
0.5125
Surprise Percent
19.3945%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.